2017 Australasian HIV & AIDS Conference joint with 2017 Australasian Sexual Health Conference National Convention Centre Canberra 6 – 9 November 2017

Click here to view the interactive program.

*Note the program is subject to change without notice

Key Topics to be presented (see full program online):

Monday 6 November:

  • Combination Prevention
  • Optimising Care, Salvage therapy  
  • Equity and access
  • Living with HIV online
  • Criminalisation
  • Co-morbidity and Toxicity
  • Vaccines
  • Cure
  • Working with Migrants
  • Trials, testing & treatment
  • PrEP

 

Tuesday 7 November:

  • Aboriginal & Torres Strait Islander Health
  • Trans Health
  • HTLV-1
  • Meanings of Safe Sex among Gay Men
  • Digital Sexual Health Promotion
  • Young People
  • Models of care and the Role of Nursing
  • Reproductive Health for Young People
  • Resistance
  • Evaluation
  • Host pathogens
  • Innovations in practice
  • Initiation, testing and diagnosis

 

Wednesday 8 November:

  • Case Presentation Breakfast
  • When Sex is Painful
  • Anti-microbial resistance
  • Self-testing
  • Bio-informatics
  • PrEP Implementation
  • Changing landscapes in Therapy
  • ‘Contentious’ issues in HIV, relationships and sexual education
  • Who is left behind in HIV elimination
  • HTLV-1
  • Ageing
  • STI Prophylaxis
  • Asia and the Pacific region

 

Thursday 9 November:

  • Reproductive Health
  • Young people’s sexual health education
  • Self-testing
  • Abortion
  • Intimate Partner Violence
  • Current Clinical Conundrums
  • Transgender Health

 

Australasian HIV&AIDS Conference Theme Outlines:

 

Theme A  The new research programmed to be presented at the ASHM conference will highlight strategies to prevent new infections and provide long term remission that will reduce the financial and complience cost of lifelong therapy. The basic science presentations in Track A include new research on HIV vaccines from Dr. Genoveffa Franchini who has worked on HIV and HTLV-1 in the National Institutes of Health laboratory where these viruses were discovered in the early 1980s. She will provide perspective build on new HIV vaccine concepts in non-human primates build on decades of work.  She will also present an understanding of how genetic variations in the Australian strains of HTLV-1 might impact on transmission and disease. Progress in basic science towards an HIV cure will be presented by Dr. Rowena Johnston who is research director for the AmFAR.  Research from our region highlights insights into the location, measurement and structure of the HIV reservoir that persists during effective cART. In addition new insights into how to generate antibodies that neutralise and prevent cell-cell transmission of HIV will be presented in the basic science sessions.  HIV basic research presented at the conference provides tangible progress and hope for solving the remaining vexing obstacles preventing the eradication of HIV. 

 

Theme B programming includes many key presentations to help clinicians look after their patients better; to guide PLHIV on how treatment changes will affect their lived experience and has implications for further HIV related research.  A snapshot of what will be covered includes:

  • Co-morbidities, toxicities growing old with HIV in Australia and the region
  • Optimising care – quality of life, quality of therapy and quality of guidelines
  • “If all I have is a hammer” – when to change the antiretrovirals versus when to add drugs to treat osteoporosis and other morbidities

 

Theme C will cover the latest research on the epidemiology and prevention of HIV, including: 

  • Understanding gaps in access and inequity in the prevention response and initiatives to address these gaps
  • Implementation and behavioural research on PrEP in Australia and overseas
  • Treatment as prevention - how can it be optimized?
  • Tracking progress to elimination - how do we do it?

 

Theme D will cover:

  • How priority populations and other communities are making sense of and adapting to the increasing role of biomedical technologies within combination prevention
  • Why thinking meaningfully about diverse experiences of gender and sexuality can strengthen both effectiveness and inclusiveness in HIV prevention, services and research
  • What we can learn from those communities whose health is put at risk by criminalisation and other punitive policy frameworks
  • Where and why HIV policy can be extended to encompass the distinctive needs and preferences of minority groups